Krystal Biotech
KRYS
#2779
Rank
NZ$8.38 B
Marketcap
$291.53
Share price
2.49%
Change (1 day)
48.20%
Change (1 year)

Krystal Biotech (KRYS) - Cash on Hand

Cash on Hand as of September 2024 : NZ$1.04 Billion

According to Krystal Biotech's latest financial reports the company has NZ$1.04 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Krystal Biotech - Cash on Hand chart (from 2016 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.84 B40.91%
2022-12-31NZ$0.59 B-6.89%
2021-12-31NZ$0.64 B70.61%
2020-12-31NZ$0.37 B30.72%
2019-12-31NZ$0.28 B72.61%
2018-12-31NZ$0.16 B138.61%
2017-12-31NZ$69.82 M2415.24%
2016-12-31NZ$2.77 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.48 B-53.70%๐Ÿ‡บ๐Ÿ‡ธ USA